Buscar
01/04/2026
Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study)
Monge, A, Martinez-De las Fuentes, AM, Burgos, J, Pou, C, Lakhani, JS, Navarro, A, Castanon, RA, Garcia-Urrestarazu, EJ, Sayés, A, Alcaide, AB, Erro, M, Moreno, BR, Sánchez-Cucó, A, Santisteve, S, Benitez, ID, Moncusi-Moix, A, Gracia-Lavedan, E, Manzano, C, Morales, A, Barbé, F, Suarez-Cuartin, G, de la Rosa-Carrillo, D, de-Torres, JP, González, J. Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study). ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(4)DOI:10.1016/j.arbres.2025.10.017. PMID:41253672. IF:9.200(Q1/1D).
01/02/2026
LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY
Lázaro, AR, Mediano, O, Cano, I, Egea, C, Monasterio, M, Muñoz, C, Podzamczer, I, Gonzalez, M, Grau, N, Cabriada, V, Cano, MDP, Dalmases, M, Salord, N, Castelló, C, Ramos, A, Lores, V, Arias, B, Jara, B, Ruiz, C, Horrillo, A, Romero, S, Pozuelo, L, Martinez, D, Boukichou, N, Barbé, F, de la Torre, MS. LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY. SLEEP MEDICINE. 2026; 138DOI:. PMID:. IF:3.400(Q2/3D).
01/01/2026
Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study
Gessner, C, Russell, REK, Greulich, T, Lommatzsch, M, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Kupczyk, M, Braido, F, Piraino, A, Scaffidi-Argentina, U, Bogoevska, V, Trinkmann, F. Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study. Journal of Asthma and Allergy. 2026; 19DOI:10.2147/JAA.S582286. PMID:41767174. IF:3.000(Q2/4D).
01/03/2026
REAL-WORLD EVIDENCE FOR FIXED TRIPLE THERAPY WITH BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM IN ASTHMA PATIENTS WITH CONCOMITANT COPD: SIX-MONTH RESULTS OF TRIMAXIMIZE
Harniman, K, Gessner, C, Bogoevska, V, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Fritz, C, Hahn, A, Trinkmann, F. REAL-WORLD EVIDENCE FOR FIXED TRIPLE THERAPY WITH BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM IN ASTHMA PATIENTS WITH CONCOMITANT COPD: SIX-MONTH RESULTS OF TRIMAXIMIZE. INTERNAL MEDICINE JOURNAL. 2026; 56DOI:. PMID:. IF:1.500(Q2/5D).
13/04/2026
Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis
Blanco, R, Rua-Figueroa, I, Blanco-Aparicio, M, Casafont-Solé, I, Espígol-Frigolé, G, García-Moguel, I, Plaza, V, Soto-Campos, G. Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis. Frontiers in Immunology. 2026; 17DOI:10.3389/fimmu.2026.1785849. PMID:42051495. IF:5.900(Q1/2D).
01/07/2025
FEV1Q as a Predictive Metric for Asthma Outcomes
Betancor, D, Olaguibel, JM, del Pozo, V, Puebla, MJA, Arismendi, E, Barroso, B, Bobolea, I, Cardaba, B, Cañas, JA, Domínguez-Ortega, J, Cruz, MJ, Curto, E, Garcia de la Fuente, A, González-Barcala, FJ, Luna-Porta, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Picado, C, Plaza, V, Quirce, S, Rial, MJ, Soto-Retes, L, Valverde-Monge, M, Mahíllo-Fernández, I, Sastre, J. FEV1Q as a Predictive Metric for Asthma Outcomes. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(7)DOI:10.1016/j.arbres.2025.02.011. PMID:40087119. IF:9.200(Q1/1D).
01/03/2026
SEPAR Recommendations on Vaccination for Chronic Respiratory Patients
de Miguel-Díez, J, Torres-Castro, R, Herrero, FS, Villanueva, RM, Gómez, BS, Fernández, SQ, Rojo, RP, Cuesta, VMM, Castillo, ME, Fernández, LS, Martínez, MMC, Mediano, O, García-Ortega, A, Rivero, JLG, de la Rosa-Carrillo, D. SEPAR Recommendations on Vaccination for Chronic Respiratory Patients. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(3)DOI:10.1016/j.arbres.2025.06.005. PMID:40592680. IF:9.200(Q1/1D).
01/07/2025
Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).
Almonacid C, Blanco M, Ferreira J, García G, Morete A, Quirce S, Soto-Campos G, Plaza V. Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).. Open Respiratory Archives. 2025; 7(3)DOI:10.1016/j.opresp.2025.100453. PMID:40677934. IF:(Q/D).